Publication | Open Access
Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma
81
Citations
29
References
2016
Year
Neuro-oncologyGliomaMedicinePharmacologyPhase Ii StudyOral Vegfr InhibitorPharmacotherapyAnti-cancer AgentHigh-grade GliomasCancer TreatmentRecurrent GlioblastomaOncologyRadiation OncologyMolecular Oncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1